IRMD
Price
$53.38
Change
+$0.65 (+1.23%)
Updated
Apr 24, 01:48 PM (EDT)
Capitalization
557.04M
7 days until earnings call
VREX
Price
$7.60
Change
+$0.31 (+4.25%)
Updated
Apr 23 closing price
Capitalization
732.76M
12 days until earnings call
Ad is loading...

IRMD vs VREX

Header iconIRMD vs VREX Comparison
Open Charts IRMD vs VREXBanner chart's image
iRadimed
Price$53.38
Change+$0.65 (+1.23%)
Volume$100
Capitalization557.04M
Varex Imaging
Price$7.60
Change+$0.31 (+4.25%)
Volume$673.41K
Capitalization732.76M
IRMD vs VREX Comparison Chart
Loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRMD vs. VREX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a StrongBuy and VREX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (IRMD: $52.73 vs. VREX: $7.60)
Brand notoriety: IRMD and VREX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRMD: 98% vs. VREX: 141%
Market capitalization -- IRMD: $557.04M vs. VREX: $732.76M
IRMD [@Medical Specialties] is valued at $557.04M. VREX’s [@Medical Specialties] market capitalization is $732.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 2 FA rating(s) are green whileVREX’s FA Score has 0 green FA rating(s).

  • IRMD’s FA Score: 2 green, 3 red.
  • VREX’s FA Score: 0 green, 5 red.
According to our system of comparison, IRMD is a better buy in the long-term than VREX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 5 TA indicator(s) are bullish while VREX’s TA Score has 5 bullish TA indicator(s).

  • IRMD’s TA Score: 5 bullish, 2 bearish.
  • VREX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than VREX.

Price Growth

IRMD (@Medical Specialties) experienced а +1.48% price change this week, while VREX (@Medical Specialties) price change was +6.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

Reported Earning Dates

IRMD is expected to report earnings on Jul 31, 2025.

VREX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VREX($733M) has a higher market cap than IRMD($557M). IRMD has higher P/E ratio than VREX: IRMD (31.84) vs VREX (18.22). IRMD YTD gains are higher at: -3.837 vs. VREX (-47.910). VREX has higher annual earnings (EBITDA): 85.6M vs. IRMD (20.8M). VREX has more cash in the bank: 141M vs. IRMD (49.8M). IRMD has less debt than VREX: IRMD (2.04M) vs VREX (470M). VREX has higher revenues than IRMD: VREX (878M) vs IRMD (65.6M).
IRMDVREXIRMD / VREX
Capitalization557M733M76%
EBITDA20.8M85.6M24%
Gain YTD-3.837-47.9108%
P/E Ratio31.8418.22175%
Revenue65.6M878M7%
Total Cash49.8M141M35%
Total Debt2.04M470M0%
FUNDAMENTALS RATINGS
IRMD vs VREX: Fundamental Ratings
IRMD
VREX
OUTLOOK RATING
1..100
245
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
26100
SMR RATING
1..100
4091
PRICE GROWTH RATING
1..100
5195
P/E GROWTH RATING
1..100
3537
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (16) in the Medical Specialties industry is significantly better than the same rating for VREX (84). This means that IRMD’s stock grew significantly faster than VREX’s over the last 12 months.

IRMD's Profit vs Risk Rating (26) in the Medical Specialties industry is significantly better than the same rating for VREX (100). This means that IRMD’s stock grew significantly faster than VREX’s over the last 12 months.

IRMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for VREX (91). This means that IRMD’s stock grew somewhat faster than VREX’s over the last 12 months.

IRMD's Price Growth Rating (51) in the Medical Specialties industry is somewhat better than the same rating for VREX (95). This means that IRMD’s stock grew somewhat faster than VREX’s over the last 12 months.

IRMD's P/E Growth Rating (35) in the Medical Specialties industry is in the same range as VREX (37). This means that IRMD’s stock grew similarly to VREX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRMDVREX
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
60%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
59%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
62%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 9 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
65%
View a ticker or compare two or three
Ad is loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIVPX15.340.18
+1.19%
MAI Managed Volatility Investor
CMCIX24.23N/A
N/A
Calvert Small/Mid-Cap I
PEIOX36.54N/A
N/A
Principal Equity Income R3
CDWCX10.75N/A
N/A
American Funds Dvlpg Wld Gr&Inc 529C
FIKEX46.50N/A
N/A
Fidelity Advisor Industrials Z

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+1.23%
HBIO - IRMD
46%
Loosely correlated
+0.97%
VREX - IRMD
43%
Loosely correlated
+4.25%
AORT - IRMD
43%
Loosely correlated
+2.19%
ITGR - IRMD
41%
Loosely correlated
+2.14%
SIBN - IRMD
40%
Loosely correlated
+1.39%
More

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with ATR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then ATR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
+4.25%
ATR - VREX
53%
Loosely correlated
+1.39%
NVST - VREX
50%
Loosely correlated
+3.63%
ALGN - VREX
44%
Loosely correlated
+1.93%
IRMD - VREX
43%
Loosely correlated
+1.23%
HBIO - VREX
42%
Loosely correlated
+0.97%
More